Literature DB >> 30604288

Identification of the multivalent PDZ protein PDZK1 as a binding partner of sodium-coupled monocarboxylate transporter SMCT1 (SLC5A8) and SMCT2 (SLC5A12).

Sunena Srivastava1, Kiyoshi Nakagawa2, Xin He1,3, Toru Kimura1, Toshiyuki Fukutomi1, Seiji Miyauchi4, Hiroyuki Sakurai1, Naohiko Anzai5.   

Abstract

Sodium-coupled monocarboxylate transporters SMCT1 (SLC5A8) and SMCT2 (SLC5A12) mediate the high- and low-affinity transport of lactate in the kidney, but their regulatory mechanism is still unknown. Since these two transporters have the PDZ-motif at their C-terminus, the function of SMCTs may be modulated by a protein-protein interaction. To investigate the binding partner(s) of SMCTs in the kidney, we performed yeast two-hybrid (Y2H) screenings of a human kidney cDNA library with the C-terminus of SMCT1 (SMCT1-CT) and SMCT2 (SMCT2-CT) as bait. PDZK1 was identified as a partner for SMCTs. PDZK1 coexpression in SMCT1-expressing HEK293 cells enhanced their nicotinate transport activity. PDZK1, SMCT1, and URAT1 in vitro assembled into a single tri-molecular complex and their colocalization was confirmed in the renal proximal tubule in vivo by immunohistochemistry. These results indicate that the SMCT1-PDZK1 interaction thus plays an important role in both lactate handling as well as urate reabsorption in the human kidney.

Entities:  

Keywords:  Lactate; Monocarboxylate transporter; Monocarboxylates; PDZ; PDZK1; SMCT

Mesh:

Substances:

Year:  2019        PMID: 30604288     DOI: 10.1007/s12576-018-00658-1

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  33 in total

1.  The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus.

Authors:  Naohiko Anzai; Hiroki Miyazaki; Rie Noshiro; Suparat Khamdang; Arthit Chairoungdua; Ho-Jung Shin; Atsushi Enomoto; Shinichi Sakamoto; Taku Hirata; Kimio Tomita; Yoshikatsu Kanai; Hitoshi Endou
Journal:  J Biol Chem       Date:  2004-08-10       Impact factor: 5.157

2.  Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains.

Authors:  O Kocher; N Comella; K Tognazzi; L F Brown
Journal:  Lab Invest       Date:  1998-01       Impact factor: 5.662

3.  The PDZ domain protein PDZK1 interacts with human peptide transporter PEPT2 and enhances its transport activity.

Authors:  R Noshiro; N Anzai; T Sakata; H Miyazaki; T Terada; H J Shin; X He; D Miura; K Inui; Y Kanai; H Endou
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

4.  Characterization of a protein cofactor that mediates protein kinase A regulation of the renal brush border membrane Na(+)-H+ exchanger.

Authors:  E J Weinman; D Steplock; Y Wang; S Shenolikar
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

5.  PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein.

Authors:  O Kocher; N Comella; A Gilchrist; R Pal; K Tognazzi; L F Brown; J H Knoll
Journal:  Lab Invest       Date:  1999-09       Impact factor: 5.662

Review 6.  Biological functions of SLC5A8, a candidate tumour suppressor.

Authors:  V Ganapathy; E Gopal; S Miyauchi; P D Prasad
Journal:  Biochem Soc Trans       Date:  2005-02       Impact factor: 5.407

7.  Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2).

Authors:  Sonne R Srinivas; Elangovan Gopal; Lina Zhuang; Shirou Itagaki; Pamela M Martin; You-Jun Fei; Vadivel Ganapathy; Puttur D Prasad
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

8.  Drug discovery for hyperuricemia.

Authors:  Naohiko Anzai; Hitoshi Endou
Journal:  Expert Opin Drug Discov       Date:  2007-09       Impact factor: 6.098

9.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.

Authors:  Hui Li; Lois Myeroff; Dominic Smiraglia; Michael F Romero; Theresa P Pretlow; Lakshmi Kasturi; James Lutterbaugh; Ronald M Rerko; Graham Casey; Jean-Pierre Issa; Joseph Willis; James K V Willson; Christoph Plass; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

10.  Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney.

Authors:  E Gopal; N S Umapathy; P M Martin; S Ananth; J P Gnana-Prakasam; H Becker; C A Wagner; V Ganapathy; P D Prasad
Journal:  Biochim Biophys Acta       Date:  2007-07-14
View more
  5 in total

1.  Sodium-coupled monocarboxylate transporter 1 interacts with the RING finger- and PDZ domain-containing protein PDZRN3.

Authors:  Yusuke Otsuka; Tomomi Furihata; Kiyoshi Nakagawa; Yuta Ohno; Yoshie Reien; Motoshi Ouchi; Hidefumi Wakashin; Shuichi Tsuruoka; Naohiko Anzai
Journal:  J Physiol Sci       Date:  2019-05-16       Impact factor: 2.781

2.  CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.

Authors:  Ze-An Zhao; Yu Jiang; Yan-Yu Chen; Ting Wu; Qun-Sheng Lan; Yong-Mei Li; Lu Li; Yang Yang; Cui-Ting Lin; Ying Cao; Ping-Zheng Zhou; Jia-Yin Guo; Yuan-Xin Tian; Jian-Xin Pang
Journal:  Acta Pharmacol Sin       Date:  2021-03-25       Impact factor: 6.150

3.  Insights Into Long Non-Coding RNA and mRNA Expression in the Jejunum of Lambs Challenged With Escherichia coli F17.

Authors:  Weihao Chen; Xiaoyang Lv; Weibo Zhang; Tingyan Hu; Xiukai Cao; Ziming Ren; Tesfaye Getachew; Joram M Mwacharo; Aynalem Haile; Wei Sun
Journal:  Front Vet Sci       Date:  2022-04-12

4.  Differences of Uric Acid Transporters Carrying Extracellular Vesicles in the Urine from Uric Acid and Calcium Stone Formers and Non-Stone Formers.

Authors:  Zhijian Lin; Muthuvel Jayachandran; Zejfa Haskic; Sanjay Kumar; John C Lieske
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

Review 5.  Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application.

Authors:  Gergely Gyimesi; Jonai Pujol-Giménez; Yoshikatsu Kanai; Matthias A Hediger
Journal:  Pflugers Arch       Date:  2020-08-07       Impact factor: 3.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.